OneSpan (OSPN): Director Marc Zenner Buys 2,200 Shares at $12.80
OneSpan director Marc Zenner purchased 2,200 shares of OneSpan Inc. (OSPN) on 08/08/2025 at $12.80 per share, increasing his direct holdings to 71,273 shares.
Rhea-AI Filing Summary
OneSpan director Marc Zenner purchased 2,200 shares of OneSpan Inc. (OSPN) on 08/08/2025 at $12.80 per share, increasing his direct holdings to 71,273 shares. The transaction is reported on a Form 4 filed by one reporting person and was signed by attorney-in-fact Lara Mataac on 08/08/2025.
Positive
- None.
Negative
- None.
Insights
Director purchase of 2,200 OSPN shares reported; modest size likely limited market impact.
The filing shows Marc Zenner, identified as a director, acquired 2,200 shares of OneSpan at $12.80 per share on 08/08/2025, bringing his direct holdings to 71,273 shares. The purchase totals approximately $28,160. As a single-line Form 4 disclosure, this is a routine insider purchase disclosure with no other transactions or derivative activity reported.
Routine insider buy by a director; disclosure is complete and properly signed by attorney-in-fact.
The Form 4 identifies the reporting person as a director and records a non-derivative purchase of 2,200 common shares at $12.80, resulting in 71,273 shares beneficially owned directly. The form is filed by one reporting person and bears a signature block executed by an attorney-in-fact, Lara Mataac, dated 08/08/2025. No derivative transactions or additional material events are disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,200 | $12.80 | $28K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Marc Zenner report on the OneSpan (OSPN) Form 4?
Who filed and signed the Form 4 for Marc Zenner's transaction?
Were any derivative securities reported in this OneSpan Form 4?
What is the total monetary value of the purchase disclosed on the Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.